Work

A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study

Year: 2015

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2015.11.027

Authors: Elizabeth R. Burton, Mark Brady, Howard D. Homesley, Peter G. Rose, Toshiaki Nakamura, Joshua P. Kesterson, Jacob Rotmensch, J. Tate Thigpen, Linda Van Le

Institutions: Abington Memorial Hospital, Roswell Park Comprehensive Cancer Center, NRG Oncology, East Carolina University, Cleveland Clinic, Kagoshima City Hospital, Penn State Milton S. Hershey Medical Center, Rush University Medical Center, Rush University, University of Mississippi Medical Center, University of North Carolina at Chapel Hill

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G1950154987, GYNECOLOGIC ONCOLOGY GROUP STATISTICAL AND DATA CENTER, NRG Oncology Network Group Operations Center, Gynecologic Oncology Group, G70736214, NRG Oncology - Statistical and Data Management Center

OpenAlex ID: W2175293021

FWCI: 2.762

Cites: 29

Cited by: 35

Related to: 10